Methotrexate (MTX) is the first line of choice for the management of rheumatoid arthritis (RA) and has been reported for its low bioavailability and side effects. Combination therapy has been widely investigated to overcome bioavailability issues and to reduce adverse effects associated with monotherapy. Various phytoconstituents such as resveratrol (RSV) and curcumin have been found to possess potent anti-inflammatory activity via downregulating the signaling of cytokines (interleukin [IL]-1, IL-6, and tumor necrosis factor alpha) and nuclear factor kappa B signaling. The prime objective of this study was to develop transdermal gel containing MTX–RSV loaded nanoemulsions (NEs) to overcome bioavailability issues and adverse effects of RA monotherapy. The NEs optimized by using Box–Behnken Design were incorporated within gel, and an in vitro skin permeation study performed on rat skin by using vertical Franz diffusion cells exhibited controlled drug release up to 48 h. Subsequently, anti-inflammatory and potential anti-arthritic activities of the combination in nanocarrier were assessed in rats and showed 78.76 ± 4.16% inhibition in inflammation and better anti-arthritic effects. Consequently, integration of dual delivery with nanotechnology can hopefully produce successful therapeutic options for rheumatic diseases.
Get full access to this article
View all access options for this article.
References
1.
Van der WoudeD, Van der Helm-van MilAHM: Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Gastroenterol, 2018; 32:174–187.
2.
RidgleyLA, AndersonAE, PrattAG: What are the dominant cytokines in early rheumatoid arthritis?. Curr Opin Rheumatol, 2018; 30:207–214.
3.
AletahaD, SmolenJS: Diagnosis and management of rheumatoid arthritis: a review. JAMA, 2018; 320:1360–1372.
4.
KielyPDW, NikiphorouE: Management of rheumatoid arthritis. Medicine, 2018; 46:216–221.
5.
AbbasiM, MousaviMJ, JamalzehiS, et al.: Strategies toward rheumatoid arthritis therapy; the old and the new. J Cell Physiol, 2019; 234:10018–10031.
6.
FriedmanB, CronsteinB: Methotrexate mechanism in treatment of rheumatoid arthritis. Joint Bone Spine, 2019; 86:301–307.
SureshE, LambertCM: Combination treatment strategies in early rheumatoid arthritis. Ann Rheum Dis, 2005; 64:1252–1256.
9.
PandeyS, KumarV, LeekhaA, et al.: Co-delivery of teriflunomide and methotrexate from hydroxyapatite nanoparticles for the treatment of rheumatoid arthritis: in vitro characterization, pharmacodynamic and biochemical investigations. Pharm Res, 2018; 35:201–213.
10.
Reum SonA, KimDY, Hun ParkS, et al.: Direct chemotherapeutic dual drug delivery through intra-articular injection for synergistic enhancement of rheumatoid arthritis treatment. Sci Rep, 2015; 5:14713–14720.
11.
SunY, YaoY, DingCZ: A combination of sinomenine and methotrexate reduces joint damage of collagen induced arthritis in rats by modulating osteoclast-related cytokines. Int Immunopharmacol, 2014; 18:135–141.
12.
HarikumarKB, AggarwalBB: Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle, 2008; 7:1020–1035.
13.
EnglerA, TangeC, Frank-BertonceljM, GayRE, GayS, OspeltC: Regulation and function of SIRT1 in rheumatoid arthritis synovial fibroblasts. J Mol Med (Berl), 2016; 94:173–182.
14.
CheonYH, KimHO, SuhY, et al.: Inhibitory effects for rheumatoid arthritis of dietary supplementation with resveratrol in collagen-induced arthritis. J Rheum Dis, 2015; 22:93–101.
15.
NakayamaH, YaguchiT, YoshiyaS, NishizakiT: Resveratrol induces apoptosis MH7A human rheumatoid arthritis synovial cells in a sirtuin 1-dependent manner. Rheumatol Int, 2012; 32:151–157.
16.
KhojahHM, AhmedS, Abdel-RahmanMS, ElhakeimEH: Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study. Clin Rheumatol, 2018; 37:2035–2042.
17.
SalimN, AhmadN, MusaS, HashimR, TadrosT, BasriM: Nanoemulsion as a topical delivery system of antipsoriatic drugs. RSC Adv, 2016; 66:6234–6250.
18.
RaiVK, MishraN, YadavKS, YadavNP: Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: formulation development, stability issues, basic considerations and applications. J Control Release, 2018; 270:203–225.
19.
KumarS, LatherV, PanditaD: Stability indicating simplified HPLC method for simultaneous analysis of resveratrol and quercetin in nanoparticles and human plasma. Food Chem, 2016; 197:959–964.
20.
PundS, ThakurR, MoreU, JoshiA: Lipid based nanoemulsifying resveratrol for improved physicochemical characteristics, in vitro cytotoxicity and in vivo antiangiogenic efficacy. Colloids Surf B Biointerfaces, 2014; 120:110–117.
21.
JainAK, ThankiK, JainS: Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part II in vivo pharmacokinetics, antitumor efficacy and hepatotoxicity. Pharm Res, 2014; 31:946–958.
22.
KaurR, AjithaM: Transdermal delivery of fluvastatin loaded nanoemulsion gel: preparation, characterization and in vivo anti-osteoporosis activity. Eur J Pharm Sci, 2019; 136:104956.
23.
NaralaA, GudaS, VeerabrahmaK: Lipid nanoemulsions of rebamipide: formulation, characterization, and in vivo evaluation of pharmacokinetic and pharmacodynamic effects. AAPS Pharm Sci Tech, 2019; 20:20–26.
24.
PillaiAB, NairJV, GuptaNK, GuptaS: Microemulsion-loaded hydrogel formulation of butenafine hydrochloride for improved topical delivery. Arch Dermatol Res, 2015; 307:625–633.
25.
LatherV, SharmaD, PanditaD: Proniosomal gel-mediated transdermal delivery of bromocriptine: in vitro and ex vivo evaluation. J Exp Nanosci, 2016; 11:1044–1057.
26.
Moghaddam AtefehA, AhadA, AqilM, Ahmad FarhanJ, SultanaY, AliA: Ibuprofen loaded nano-ethanolic liposomes carbopol gel system: in vitro characterization and anti-inflammatory efficacy assessment in Wistar rats. J Polym Eng, 2018; 38:291–298.
27.
PatelMG, PundarikakshuduK: Anti-arthritic activity of a classical ayurvedic formulation Vatari Guggulu in rats. J Tradit Complement Med, 2016; 6:389–394.
28.
VoraD, HeruyeS, KumariD, et al.: Preparation, characterization and antioxidant evaluation of poorly soluble polyphenol-loaded nanoparticles for cataract treatment. AAPS Pharm Sci Tech, 2019; 20:163.
29.
GumireddyA, ChristmanR, KumariD, et al.: Preparation, characterization, and in vitro evaluation of curcumin-and resveratrol-loaded solid lipid nanoparticles. AAPS Pharm Sci Tech, 2019; 20:145.
30.
KunduP, DasM, TripathyK, et al.: Delivery of dual drug loaded lipid based nanoparticles across the blood-brain barrier impart enhanced neuroprotection in a rotenone induced mouse model of Parkinson's disease. ACS Chem Neurosci, 2016; 7:1658–1670.
31.
AzeemA, RizwanM, AhmadFJ, et al.: Nanoemulsion components screening and selection: a technical note. AAPS Pharm Sci Tech, 2009; 10:69–76.
32.
SuR, YangL, WangY, et al.: Formulation, development, and optimization of a novel octyldodecanol-based nanoemulsion for transdermal delivery of ceramide IIIB. Int J Nanomed, 2017; 12:5203–5221.
33.
FachelFNS, Medeiros-NevesB, Dal PraM, et al.: Box–Behnken design optimization of mucoadhesive chitosan-coated nanoemulsions for rosmarinic acid nasal delivery-in vitro studies. Carbohydr Polym, 2018; 199:572–582.
34.
PooniaN, Kaur NarangJ, LatherV, et al.: Resveratrol loaded functionalized nanostructured lipid carriers for breast cancer targeting: systematic development, characterization and pharmacokinetic evaluation. Colloids Surf B Biointerfaces, 2019; 181:756–766.
35.
Da SilvaJD, GomesMV, CabralLM, De SousaVP: Evaluation of the in vitro release and permeation of Cordia verbenacea DC essential oil from topical dosage forms. J Drug Deliv Sci Technol, 2019; 53:101–123.
36.
AroraR, AggarwalG, HarikumarSL, KaurK: Nanoemulsion based hydrogel for enhanced transdermal delivery of ketoprofen. Adv Pharm, 2014; 2:1–12.
37.
HarwanshRK, MukherjeePK, BahadurS, BiswasR: Enhanced permeability of ferulic acid loaded nanoemulsion based gel through skin against UVA mediated oxidative stress. Life Sci, 2015; 141:202–211.
38.
TangSY, SivakumarM, NgAM-H, ShridharanP: Anti-inflammatory and analgesic activity of novel oral aspirin-loaded nanoemulsion and nano multiple emulsion formulations generated using ultrasound cavitation. Int J Pharm, 2012; 430:299–306.
39.
OsmanAS, LabibDA, KamelMM: Carvedilol can attenuate histamine-induced paw edema and formaldehyde-induced arthritis in rats without risk of gastric irritation. Int Immunopharmacol, 2017; 50:243–250.
40.
CoradiniK, FriedrichRB, FonsecaFN, et al.: A novel approach to arthritis treatment based on resveratrol and curcumin co-encapsulated in lipid-core nanocapsules: in vivo studies. Eur J Pharm Sci, 2015; 78:163–170.
41.
BanjiD, PinnapureddyJ, BanjiOJ, SaiduluA, HayathMS: Synergistic activity of curcumin with methotrexate in ameliorating Freund's complete adjuvant induced arthritis with reduced hepatotoxicity in experimental animals. Eur J Pharmacol, 2011; 668:293–298.
